home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

p53 Needs p63 And p73

 
  April, 8 2002 8:24
your information resource in human molecular genetics
 
     
The gene p53 is the focus of considerable clinical interest as it is frequently mutated in human cancers. The protein it encodes, p53, is an important part of the cell-suicide system that keeps DNA damage in check.

This week researchers report in Nature (Vol. 416, No. 6880, 04 Apr 02) that p53-mediated hara-kiri also seems to depend upon two other proteins, called p63 and p73. If both these are absent p53 seems unable to nip DNA damage in the bud.

"These data may portend a greater role for these proteins in tumour suppression and chemosensitivity," conclude Tyler Jacks of the Massachusetts Institute of Technology, Cambridge, Massachusetts, and the Howard Hughes Medical Institute, Chevy Chase, Maryland, and colleagues.

CONTACT:

Tyler Jacks
tel +1 617 253 0262,
e-mail tjacks@mit.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.